Related references
Note: Only part of the references are listed.Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in nasopharyngeal carcinoma
Shanthi Sabarimurugan et al.
PLOS ONE (2019)
FSTL1 enhances chemoresistance and maintains stemness in breast cancer cells via integrin β3/Wnt signaling under miR-137 regulation
Shaoqiang Cheng et al.
CANCER BIOLOGY & THERAPY (2019)
Conceptual interpretation of analysing and reporting of results on systematic review and meta-analysis of optimal extent of lateral neck dissection for well-differentiated thyroid carcinoma with metastatic lateral neck lymph nodes
Rama Jayaraj et al.
ORAL ONCOLOGY (2019)
Comment on, Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis
Rama Jayaraj et al.
ORAL ONCOLOGY (2019)
Letter to the Editor regarding, The prognostic role of PD-L1 expression for survival in head and neck squamous cell carcinoma: A systematic review and meta-analysis
Rama Jayaraj et al.
ORAL ONCOLOGY (2019)
Letter to the Editor about the Article: Performance of different imaging techniques in the diagnosis of head and neck cancer mandibular invasion: A systematic review and meta-analysis
Rama Jayaraj et al.
ORAL ONCOLOGY (2019)
Commentary: Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis
Rama Jayaraj et al.
FRONTIERS IN PHYSIOLOGY (2019)
miR-125b regulates the drug-resistance of breast cancer cells to doxorubicin by targeting HAX-1
Guinv Hui et al.
ONCOLOGY LETTERS (2018)
MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer
San-Jian Yu et al.
BMC CANCER (2018)
Comment on 'Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis'
Rama Jayaraj et al.
BRITISH JOURNAL OF CANCER (2018)
MicroRNA-708-3p mediates metastasis and chemoresistance through inhibition of epithelial-to-mesenchymal transition in breast cancer
Jin-Won Lee et al.
CANCER SCIENCE (2018)
Letter to the editor: is HIF-1α a viable prognostic indicator in OSCC? A critical review of a meta-analysis study
Rama Jayaraj et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2018)
Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients
Shanthi Sabarimurugan et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Letter to the Editor in response to the article, The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis
Rama Jayaraj et al.
ORAL ONCOLOGY (2018)
Systematic review and meta-analysis of risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: Approaches and strategies
Rama Jayaraj et al.
ORAL ONCOLOGY (2018)
Head and neck cancer risk factors in India: protocol for systematic review and meta-analysis
Aayush Poddar et al.
BMJ OPEN (2018)
Letter to the editor Prognostic value of microRNAs in colorectal cancer: a meta-analysis
Rama Jayaraj et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Comment on Systematic Review and Meta-Analysis of Diagnostic Accuracy of miRNAs in Patients with Pancreatic Cancer
Rama Jayaraj et al.
DISEASE MARKERS (2018)
Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India Protocol for a systematic review and meta-analyses
Madurantakam Royam Madhav et al.
MEDICINE (2018)
Systematic review and meta-analysis of cancer studies evaluating diagnostic test accuracy and prognostic values: approaches to improve clinical interpretation of results
Rama Jayaraj et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol
Chellan Kumarasamy et al.
SYSTEMATIC REVIEWS (2018)
A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance
Wengong Si et al.
CELL DEATH AND DIFFERENTIATION (2018)
Epigenetic Silencing of miR-200c in Breast Cancer Is Associated With Aggressiveness and Is Modulated by ZEB1
Valentina Damiano et al.
GENES CHROMOSOMES & CANCER (2017)
Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer
Wanli Yang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer
Weijiang Zhang et al.
GENE (2017)
MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel
Fan Yang et al.
GENE (2017)
A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer
Masataka Nakano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
MicroRNA-218 promotes cisplatin resistance in oral cancer via the PPP2R5A/Wnt signaling pathway
Zehang Zhuang et al.
ONCOLOGY REPORTS (2017)
MicroRNA-181a promotes docetaxel resistance in prostate cancer cells
Cameron M. Armstrong et al.
PROSTATE (2017)
Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly
Xiaoti Lin et al.
THERANOSTICS (2017)
miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway
S-L Tung et al.
ONCOGENESIS (2017)
MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway
Yuan Miao et al.
SCIENTIFIC REPORTS (2017)
Epidemiology of breast cancer in Indian women
Shreshtha Malvia et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma
Luigi Fattore et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
MicroRNAs are important regulators of drug resistance in colorectal cancer
Yang Zhang et al.
BIOLOGICAL CHEMISTRY (2017)
The Role of MicroRNAs in Diagnosis, Prognosis, Metastasis and Resistant Cases in Breast Cancer
Seong Lin Teoh et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Potentiation of docetaxel sensitivity by miR-638 via regulation of STARD10 pathway in human breast cancer cells
Ge Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
microRNA-210 overexpression inhibits tumor growth and potentially reverses gemcitabine resistance in pancreatic cancer
Prince Saforo Amponsah et al.
CANCER LETTERS (2017)
MiR-148a and miR-152 reduce tamoxifen resistance in ER plus breast cancer via downregulating ALCAM
Ming-Jenn Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP
Samir Jana et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
miR-520h is crucial for DAPK2 regulation and breast cancer progression
C-M Su et al.
ONCOGENE (2016)
Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer
J. Niu et al.
ONCOGENE (2016)
miR-181b promotes chemoresistance in breast cancer by regulating Bim expression
Yabing Zheng et al.
ONCOLOGY REPORTS (2016)
miR-27a regulates the sensitivity of breast cancer cells to cisplatin treatment via BAK-SMAC/DIABLO-XIAP axis
Sumei Zhou et al.
TUMOR BIOLOGY (2016)
MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer
Haifei He et al.
TUMOR BIOLOGY (2016)
Knockdown of miR-221 promotes the cisplatin-inducing apoptosis by targeting the BIM-Bax/Bak axis in breast cancer
Zhiqiang Ye et al.
TUMOR BIOLOGY (2016)
Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR
Baotong Zhang et al.
ONCOTARGET (2016)
Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling
Xin Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Circulating microRNA-451 as a predictor of resistance to neoadjuvant chemotherapy in breast cancer
Xi Gu et al.
CANCER BIOMARKERS (2016)
CCAR1 5' UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance
Gaopeng Li et al.
CELL RESEARCH (2016)
The role of miRNAs in drug resistance and prognosis of breast cancer formalin-fixed paraffin-embedded tissues
Xiu Chen et al.
GENE (2016)
Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer
Xu Chen et al.
JOURNAL OF PATHOLOGY (2016)
MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1
L. Venturutti et al.
ONCOGENE (2016)
miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway
Dan-dan Wang et al.
TUMOR BIOLOGY (2016)
Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
Jiang Zhu et al.
CELL DEATH & DISEASE (2016)
miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer
Y. Hu et al.
CELL DEATH & DISEASE (2016)
Decreased expression of microRNA-17 and microRNA-20b promotes breast cancer resistance to taxol therapy by upregulation of NCOA3
Xiang Ao et al.
CELL DEATH & DISEASE (2016)
Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9
Jian-Ping Gong et al.
ONCOLOGY LETTERS (2016)
miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1
Man Gao et al.
ONCOTARGET (2016)
MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes
Shanliang Zhong et al.
ONCOTARGET (2016)
miR-4443 Participates in the Malignancy of Breast Cancer
Xiu Chen et al.
PLOS ONE (2016)
Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer
Seema Thakur et al.
PLOS ONE (2016)
MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel
He-da Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
MicroRNA-134 modulates resistance to doxorubicin in human breast cancer cells by downregulating ABCC1
Lin Lu et al.
BIOTECHNOLOGY LETTERS (2015)
CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
Delphine R. Boulbes et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cytidine Deaminase Axis Modulated by miR-484 Differentially Regulates Cell Proliferation and Chemoresistance in Breast Cancer
Fu-Gui Ye et al.
CANCER RESEARCH (2015)
被撤回的出版物: MicroRNA-34a suppresses the breast cancer stem cell-like characteristics by downregulating Notch1 pathway (Retracted article. See APR, 2023)
Le Kang et al.
CANCER SCIENCE (2015)
miR-24-2 regulates genes in survival pathway and demonstrates potential in reducing cellular viability in combination with docetaxel
Siddharth Manvati et al.
GENE (2015)
MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy
Xinfeng Yu et al.
MOLECULAR CANCER (2015)
Effects of PI3K inhibitor NVP-BKM120 on overcoming drug resistance and eliminating cancer stem cells in human breast cancer cells
Y. Hu et al.
CELL DEATH & DISEASE (2015)
Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1
Ryou-u Takahashi et al.
NATURE COMMUNICATIONS (2015)
MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients
Leticia De Mattos-Arruda et al.
ONCOTARGET (2015)
miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A
Kazuhiro Ikeda et al.
SCIENTIFIC REPORTS (2015)
MicroRNA-574-3p, identified by microRNA library- based functional screening, modulates tamoxifen response in breast cancer
T. Ujihira et al.
SCIENTIFIC REPORTS (2015)
MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ
Mingrong Lu et al.
SCIENTIFIC REPORTS (2015)
MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells
J. Cui et al.
ONCOGENE (2015)
Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer
Jiannan Wu et al.
PLOS ONE (2015)
Identification of microRNA-93 as a functional dysregulated miRNA in triple-negative breast cancer
Jinhua Hu et al.
TUMOR BIOLOGY (2015)
MiR-218 regulates cisplatin chemosensitivity in breast cancer by targeting BRCA1
Xiao He et al.
TUMOR BIOLOGY (2015)
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
Paul Vilquin et al.
BREAST CANCER RESEARCH (2015)
miRNA expression patterns in chemoresistant breast cancer tissues
Jianxin Lv et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R
Xing-Ming Ye et al.
BMC CANCER (2014)
Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo
S. Winsel et al.
BRITISH JOURNAL OF CANCER (2014)
Prolyl Isomerase Pin1 Acts Downstream of miR200c to Promote Cancer Stem-like Cell Traits in Breast Cancer
Man-Li Luo et al.
CANCER RESEARCH (2014)
Methylation-regulated miR-149 modulates chemoresistance by targeting GlcNAc N-deacetylase/N-sulfotransferase-1 in human breast cancer
Dong-Xu He et al.
FEBS JOURNAL (2014)
MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway
Li Jiang et al.
FEBS LETTERS (2014)
The multiple facets of drug resistance: one history, different approaches
Evandro Luis Niero et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
Mao Ouyang et al.
PLOS ONE (2014)
A Methylation-Based Regulatory Network for MicroRNA 320a in Chemoresistant Breast Cancer
Dong-Xu He et al.
MOLECULAR PHARMACOLOGY (2014)
Downregulation of miRNA-128 sensitises breast cancer cell to chemodrugs by targeting Bax
Shufeng Ji et al.
CELL BIOLOGY INTERNATIONAL (2013)
The Function Role of miR-181a in Chemosensitivity to Adriamycin by Targeting Bcl-2 in Low-Invasive Breast Cancer Cells
Ying Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
MicroRNAs as therapeutic targets in chemoresistance
Michela Garofalo et al.
DRUG RESISTANCE UPDATES (2013)
Meta-analysis of microRNA expression in lung cancer
Urmo Vosa et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)
Haiyan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
miR-125b Regulates Side Population in Breast Cancer and Confers a Chemoresistant Phenotype
Hong-Jiang Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation
Flavia Pichiorri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Upregulation of miR-195 increases the sensitivity of breast cancer cells to Adriamycin treatment through inhibition of Raf-1
Ge Yang et al.
ONCOLOGY REPORTS (2013)
MicroRNA-34a Modulates Chemosensitivity of Breast Cancer Cells to Adriamycin by Targeting Notch1
Xiu-juan Li et al.
ARCHIVES OF MEDICAL RESEARCH (2012)
Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients
Eun-Jung Jung et al.
CANCER (2012)
An induction of microRNA, miR-7 through estrogen treatment in breast carcinoma
Mariko Masuda et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
Junqing Chen et al.
MEDICAL ONCOLOGY (2012)
Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer
Hongjiang Wang et al.
PLOS ONE (2012)
Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells
Kezhen Lv et al.
PLOS ONE (2012)
MicroRNA-301 Mediates Proliferation and Invasion in Human Breast Cancer
Wei Shi et al.
CANCER RESEARCH (2011)
Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
Yinghua Zhu et al.
CLINICAL CANCER RESEARCH (2011)
Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer
Chang Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor α Signaling in Breast Cancer
Yingchun Zhao et al.
MOLECULAR MEDICINE (2011)
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
Zhongxing Liang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Multiple Drug Resistance Mechanisms in Cancer
Bruce C. Baguley
MOLECULAR BIOTECHNOLOGY (2010)
Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
Diana M. Cittelly et al.
MOLECULAR CANCER (2010)
Histological types of breast cancer: How special are they?
Britta Weigelt et al.
MOLECULAR ONCOLOGY (2010)
Chemotherapy for breast cancer (Review)
M. S. U. Hassan et al.
ONCOLOGY REPORTS (2010)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
ANNALS OF INTERNAL MEDICINE (2009)
microRNA-205 Regulates HER3 in Human Breast Cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2009)
Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth
Gerard Maillot et al.
CANCER RESEARCH (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
Prevalence of and Factors Associated With Persistent Pain Following Breast Cancer Surgery
Rune Gärtner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
Heikki Joensuu et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
Helen M. Coley
CANCER TREATMENT REVIEWS (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
Olga Kovalchuk et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
Agnes Fournier et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: An update of the initial randomized study population and data of additional patients treated with the same regimen
Aman U. Buzdar et al.
CLINICAL CANCER RESEARCH (2007)
Randomized phase III study of trastuzumab, paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer
Nicholas Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer
SE Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis
S Duval et al.
BIOMETRICS (2000)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
